Microbot Achieves Study Milestone for its Robotic Surgical System

Microbot Medical Inc. has announced the first professional use of its LIBERTY Robotic Surgical System as part of a formative study.

The study was designed to enable medical professionals, including physicians and catheter lab technicians, to use and experience LIBERTY in a real-use simulated environment. The study was performed and managed by experts from a company specializing in conducting human factors and usability engineering tests of medical devices.

“Educating and establishing close relationships with our target audience enables the company to gain valuable feedback and increase awareness to our unique system. In parallel to our regulatory and pre-clinical efforts, we invest in receiving endorsements from leading experts and institutes which we believe will allow us to leverage our path to the clinical stages and later on to the market,” Microbot Chief Medical Officer Eyal Morag said.
 
The study included five teams, each consisting of an interventional radiologist and a catheter lab technician, and simulated the expected clinical setup and use of the LIBERTY Robotic Surgical System. All participants were successfully trained on the system prior to their participation and the study validated that the LIBERTY Robotic Surgical System operation and setup are intuitive.
 
Analysis and data from the study exhibited high subjective grading both by the physicians and the technicians, with no comments made on the designed operative flow.
 
Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, with the intent to improve clinical outcomes for patients and increasing accessibility through the natural and artificial lumens within the human body. The LIBERTY Robotic Surgical System aims to improve the way surgical robotics are being used in endovascular procedures today, by eliminating the need for large, cumbersome, and expensive capital equipment, while reducing radiation exposure and physician strain. The company believes the LIBERTY Robotic Surgical System’s remote operation has the potential to be the first system to democratize endovascular interventional procedures.